This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Nasopharynx
CD2_BENIGN_NASOPHARYNX_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D10
- Name in latin
- Neoplasma benignum nasopharyngis
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Nasopharynx
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Nasopharynx
- Benign neoplasm of mouth and pharynx
- Benign neoplasm of mouth and pharynx
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 312 | 155 | 157 |
| Unadjusted period prevalence (%) | 0.06 | 0.05 | 0.07 |
| Median age at first event (years) | 56.74 | 54.98 | 58.49 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 270
- Matched controls
- 2699
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D10.6
ICD-10 Finland
Benign neoplasm: Nasopharynx
+∞
320.7
240
*
EMA30
NOMESCO Finland
Biopsy of rhinopharynx
+∞
64.2
59
*
UDH02
NOMESCO Finland
Rhinopharyngoscopy
13.3
47.6
89
96
EMB30
NOMESCO Finland
Adenotomy
26.7
24.1
33
14
130
Kela drug reimbursment
Malignant tumour
+∞
21.1
20
*
WF002
NOMESCO Finland
Radical radiotherapy
+∞
17.9
17
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
+∞
16.8
16
*
21070
ICD-8 Finland
Benign neoplasm of buccal cavity and pharynx, Nasopharynx
+∞
16.8
16
*
UDQ12
NOMESCO Finland
Flexible laryngoscopy
7.6
16.8
40
60
J35.2
ICD-10 Finland
Hypertrophy of adenoids
20.8
15.8
23
12
2107A
ICD-9 Finland
Benign neoplasm of lip, oral cavity and pharynx, Nasopharynx
+∞
15.8
15
*
H02AB02
ATC
dexamethasone; systemic
47.9
15.3
18
*
DHA10
NOMESCO Finland
Biopsy of cavity of nose
26.8
14.9
20
8
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
14.7
14
*
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
13.0
13.9
24
20
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
27.4
13.5
18
7
ENA10
NOMESCO Finland
Biopsy of pharynx
73.4
12.7
14
*
D14.0
ICD-10 Finland
Benign neoplasm: Middle ear, nasal cavity and accessory sinuses
21.3
12.6
18
9
H65.2
ICD-10 Finland
Chronic serous otitis media
21.3
12.6
18
9
A03FA01
ATC
metoclopramide; systemic, rectal
3.8
12.1
54
165
WX408
NOMESCO Finland
General anesthesy, balanced
2.8
11.7
91
416
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
11.5
11
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
11.5
11
*
UDC00
NOMESCO Finland
Ear microscopy
4.8
10.9
37
87
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
15.0
10.6
17
12
C61
ICD-10 Finland
Malignant neoplasm of prostate
114.3
10.5
11
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
10.5
10
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
10.5
10
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
10.5
10
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
10.5
10
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.6
10.2
87
414
H65.3
ICD-10 Finland
Chronic mucoid otitis media
8.9
9.7
20
24
1290
FHL
Epipharyngoscopy
+∞
9.4
9
*
R01AD09
ATC
mometasone; nasal
2.2
9.3
133
815
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
5.8
9.0
25
47
XX3DW
NOMESCO Finland
Time consuming IT work
5.1
8.7
27
58
EP1AE
NOMESCO Finland
Neck ultrasound examination
6.0
8.7
23
41
A04AA01
ATC
ondansetron; systemic, rectal
8.3
8.5
18
23
115
Kela drug reimbursment
Breast cancer
+∞
8.4
8
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
8.4
8
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
8.4
8
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
8.4
8
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
8.4
8
*
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.1
8.4
145
951
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.6
8.2
63
279
Z51.5
ICD-10 Finland
Palliative care
9.4
8.2
16
18
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
3.4
8.1
40
132
TDA90
NOMESCO Finland
Removal wax from ear
15.6
7.8
12
8
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
15.6
7.8
12
8
TPH04
NOMESCO Finland
Cathetrisation of vein
2.5
7.7
67
316
H66.0
ICD-10 Finland
Acute suppurative otitis media
4.4
7.6
27
67
ENB00
NOMESCO Finland
Excision or exploration of lesion of pharynx
82.3
7.5
8
*
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
82.3
7.5
8
*
R04.0
ICD-10 Finland
Epistaxis
3.8
7.4
30
85
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
7.3
7
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
7.3
7
*
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.7
7.0
50
211
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
7.0
6.9
16
24
GD1AD
NOMESCO Finland
Thorax CT examination
5.9
6.9
18
32
H65.0
ICD-10 Finland
Acute serous otitis media
11.3
6.9
12
11
R01BA52
ATC
pseudoephedrine, combinations; oral
2.1
6.7
88
501
J39.2
ICD-10 Finland
Other diseases of pharynx
12.7
6.6
11
9
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
6.6
122
794
EMB10
NOMESCO Finland
Tonsillectomy
4.9
6.6
20
43
WF003
NOMESCO Finland
Adjuvant radiotherapy
71.5
6.5
7
*
JN4BD
NOMESCO Finland
Extensive body CT
4.2
6.4
23
59
DHB10
NOMESCO Finland
Excision of lesion of internal nose
18.5
6.3
9
5
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
6.3
6
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
6.3
6
*
C11.9
ICD-10 Finland
Malignant neoplasm: Nasopharynx, unspecified
+∞
6.3
6
*
C50
ICD-10 Finland
Malignant neoplasm of breast
+∞
6.3
6
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
6.3
6
*
H66.9
ICD-10 Finland
Otitis media, unspecified
4.1
6.3
23
60
A04AA02
ATC
granisetron; systemic, transdermal
27.4
6.3
8
*
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
27.4
6.3
8
*
Z2221
NOMESCO Finland
Medical doctor
2.1
6.2
78
433
R01AD08
ATC
fluticasone; nasal
2.1
6.1
84
485
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
62
67
11.30
53.72
1.4
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
157
739
3.26
23.46
2.6
1.6
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
181
1104
2.52
14.25
8.1
5.6
%
27.7
28.3
0.25
164
1021
(3018010) Neutrophils/100 leukocytes in Blood
179
1096
2.49
13.84
7.6
5.4
%
57.8
56.9
0.45
163
1021
(3022096) Basophils/100 leukocytes in Blood
172
1035
2.47
13.80
7.9
5.5
%
0.7
0.7
0.43
156
955
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
21
31
7.19
13.75
1.1
1.2
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
176
1075
2.46
13.60
8.0
5.5
%
2.9
3.1
0.41
159
988
(3019069) Monocytes/100 leukocytes in Blood
176
1076
2.46
13.56
8.5
5.8
%
8.7
8.5
0.39
160
1001
(42870588) Differential panel, method unspecified - Blood
136
769
2.36
12.13
8.2
5.3
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
195
1289
2.37
12.04
11.0
6.7
e9/l
4.1
4.3
0.41
165
1118
(3002256) Pathology report gross observation
49
170
3.23
11.42
1.4
1.1
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
183
1198
2.28
11.27
7.5
5.3
e9/l
1.8
1.9
1.14
163
1049
(3013115) Eosinophils [#/volume] in Blood
184
1214
2.26
11.03
8.2
5.6
e9/l
0.2
0.2
0.08
161
1057
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
38
115
3.62
10.94
3.5
1.6
ug/l
3.2
2.8
0.24
31
89
(3006315) Basophils [#/volume] in Blood
179
1174
2.23
10.81
7.6
5.3
e9/l
0.0
0.0
0.17
156
1010
(3001604) Monocytes [#/volume] in Blood
178
1167
2.22
10.73
7.6
5.3
e9/l
0.6
0.6
0.51
155
1001
(3023368) Bacteria identified in Blood by Culture
108
580
2.32
10.58
4.1
3.9
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
68
312
2.51
9.35
3.8
2.8
mmol/l
0.8
0.8
0.55
63
286
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
155
1023
2.02
8.52
5.8
4.8
mmol/l
1.2
1.2
0.06
143
914
(3024561) Albumin [Mass/volume] in Serum or Plasma
146
953
2.00
8.18
4.7
3.4
g/l
35.1
35.9
1.04
134
891
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
165
1131
1.97
7.97
7.2
5.2
mmol/l
1.2
1.2
0.16
138
980
(3021879) Hepatitis B virus core Ab [Presence] in Serum
37
135
2.97
7.87
1.2
1.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
111
665
2.04
7.85
2.6
1.9
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
71
360
2.26
7.70
2.1
1.7
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
66
327
2.29
7.55
2.0
1.8
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
91
513
2.09
7.54
2.5
1.9
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
142
944
1.93
7.32
8.8
8.8
inr
1.3
1.3
0.10
35
263
(40758558) Short blood count panel - Blood
92
537
2.01
6.86
9.0
4.8
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
189
1403
1.88
6.73
5.3
4.0
mmol/l
6.8
6.7
0.39
177
1297
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
148
1025
1.84
6.50
4.1
3.5
—
—
—
0
0
(3018418) pH of Serum or Plasma
105
652
1.92
6.49
3.4
3.2
ph
7.4
7.4
0.17
22
109
(40768795) Lymph node Pathology biopsy report
10
7
14.70
6.44
1.4
1.0
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
23
74
3.28
6.02
4.6
3.8
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
16
42
3.96
5.61
1.6
1.5
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
224
1809
1.84
5.53
10.0
5.2
u/l
80.0
75.6
0.53
209
1670
(3037467) Urinalysis macro (dipstick) panel - Urine
205
1616
1.78
5.45
6.1
4.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
16
44
3.78
5.27
1.6
1.5
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
53
277
2.10
5.23
2.6
1.7
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
23
84
2.88
4.89
2.3
1.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
14
37
3.91
4.87
1.2
1.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
45
230
2.12
4.70
1.4
1.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
23
87
2.77
4.60
2.6
1.5
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
140
1026
1.66
4.57
2.1
1.9
pmol/l
97.3
96.9
0.03
75
521
(3017181) Myelocytes/100 leukocytes in Blood
33
150
2.34
4.56
3.7
5.1
%
0.8
0.7
0.18
13
38
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
227
1894
1.73
4.41
4.6
3.8
pmol/l
14.8
14.8
0.19
209
1728
(3030467) Casts [#/volume] in Urine by Automated count
91
600
1.73
4.38
3.5
2.8
e6/l
0.2
0.4
0.99
62
446
(3013707) Erythrocyte sedimentation rate by Westergren method
221
1838
1.69
4.27
5.9
4.1
mm/h
13.9
11.1
1.85
206
1695
(3003458) Phosphate [Moles/volume] in Serum or Plasma
51
284
1.95
4.22
4.1
4.5
mmol/l
1.0
1.0
0.44
46
254
(3026493) Urate [Moles/volume] in Serum or Plasma
93
623
1.70
4.21
3.3
2.5
umol/l
323.7
9122.3
3.54
85
548
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
11
27
4.19
4.19
1.1
1.5
nmol/l
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
17
57
3.10
4.19
2.2
2.6
u/ml
0.3
0.4
0.36
11
26
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
47
255
1.99
4.18
2.0
1.8
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
30
136
2.33
4.18
1.8
1.5
g/l
1.8
1.3
0.55
25
126
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
28
123
2.40
4.18
1.8
1.6
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
17
58
3.04
4.07
2.8
3.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
97
663
1.67
4.05
3.6
2.9
e6/l
19.8
151.0
0.75
71
512
(3002179) Metamyelocytes/100 leukocytes in Blood
30
138
2.30
4.04
3.3
5.0
%
0.6
0.3
—
10
30
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
61
366
1.83
4.02
2.7
2.6
e6/l
0.8
1.0
0.28
36
210
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
11
28
4.04
4.01
1.2
1.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
12
33
3.74
3.96
1.7
1.4
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
42
224
2.01
3.92
1.8
1.8
nmol/l
312.3
364.3
0.79
36
200
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
46
256
1.93
3.81
1.9
1.8
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
104
734
1.63
3.80
3.2
2.0
mmol/l
2.4
2.4
0.00
86
615
(3021589) Normoblasts [#/volume] in Blood
138
1044
1.58
3.76
11.5
7.9
e9/l
0.0
0.0
0.66
113
855
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
49
280
1.89
3.75
1.7
2.3
%
20.7
24.4
1.40
42
248
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
16
56
2.96
3.68
1.3
1.3
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
11
30
3.76
3.67
2.7
2.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
57
347
1.79
3.57
1.6
1.8
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
10
26
3.94
3.55
1.7
1.3
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
11
31
3.64
3.51
1.1
1.5
nmol/l
0.4
0.5
0.45
11
26
(3018095) Leukocytes [#/volume] in Urine
109
791
1.58
3.50
4.0
3.4
e6/l
28.0
71.9
1.43
77
560
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
111
810
1.57
3.48
4.3
2.9
—
—
—
0
0
(3013512) EKG study
103
739
1.59
3.47
4.6
3.9
—
—
—
0
0
(3000991) Gas panel - Venous blood
35
183
2.03
3.45
7.3
6.6
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
56
343
1.77
3.43
2.9
2.8
e6/l
3.4
2.6
0.17
32
187
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
129
977
1.55
3.42
2.3
2.2
nmol/l
74.6
76.1
0.24
114
868
(3021440) Promyelocytes/100 leukocytes in Blood
29
142
2.15
3.39
3.3
5.3
%
0.2
0.1
0.45
11
34
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
49
291
1.81
3.33
1.5
1.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
33
3.42
3.22
1.6
1.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
10
28
3.66
3.22
1.7
1.3
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
44
257
1.83
3.15
1.9
2.1
%
1.8
1.7
0.08
37
233
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
61
396
1.67
3.03
1.6
1.5
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
76
522
1.60
3.03
1.7
1.7
mg/l
1.0
1.0
0.09
62
388
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
16
63
2.62
3.00
1.3
1.2
—
—
—
0
0
(3012544) pH of Venous blood
42
246
1.82
2.98
2.9
3.1
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
83
586
1.57
2.94
3.4
2.7
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
20
89
2.33
2.93
2.4
1.9
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
15
58
2.67
2.92
1.2
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
29
151
2.01
2.91
1.7
1.3
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
34
189
1.90
2.84
2.2
2.2
e9/l
72.0
68.0
0.41
26
153
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
11
36
3.13
2.83
1.1
1.1
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
45
274
1.75
2.82
6.3
5.4
mmol/l
103.9
104.4
0.20
45
266
(3019225) pH of Specimen
39
228
1.81
2.79
4.6
3.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
128
1001
1.47
2.78
2.8
2.6
ug/l
126.2
114.8
0.21
117
923
(3019309) Folate [Moles/volume] in Red Blood Cells
70
481
1.59
2.77
1.7
1.7
nmol/l
1076.0
1200.1
0.49
51
361
(3009542) Hematocrit [Volume Fraction] of Blood
250
2235
1.60
2.76
22.6
13.0
%
39.9
40.3
0.36
172
1583
(3026008) Bacteria identified in Urine by Culture
93
682
1.52
2.76
3.6
3.0
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
80
568
1.55
2.75
2.3
2.1
mg/l
2.6
3.2
1.19
63
478
(3049717) Cytology report of Urine Cyto stain
17
73
2.41
2.70
2.9
1.7
—
—
—
0
0
(3026782) Osmolality of Urine
64
433
1.60
2.70
3.2
2.4
mosm/kgh2o
531.5
560.3
0.45
54
357
(3026389) Candida sp identified in Specimen by Organism specific culture
9
24
3.83
2.69
1.4
1.2
—
—
—
0
0
(4062490)
9
24
3.83
2.69
1.8
1.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
62
417
1.61
2.68
3.1
2.2
mmol/l
2.5
2.4
1.44
52
359
(3047007) Chlamydophila sp Ab [Presence] in Serum
10
32
3.20
2.67
1.3
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
13
49
2.72
2.65
2.1
2.8
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
189
1602
1.46
2.64
3.7
3.0
u/l
46.3
44.5
0.10
180
1501
(3042631) Mycobacterium sp identified in Specimen
9
25
3.67
2.59
2.6
3.5
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
26
136
1.99
2.59
3.5
5.3
%
0.0
0.0
—
10
28
(40768800) Prostate Pathology biopsy report
6
11
5.54
2.55
1.5
1.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
10
33
3.10
2.55
1.0
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
7
16
4.45
2.49
1.0
1.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
72
512
1.53
2.44
5.8
3.8
ng/l
851.6
398.9
0.48
56
400
(3048929) Epstein Barr virus Ab [Presence] in Serum
14
58
2.48
2.40
1.2
1.2
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
99
754
1.46
2.40
2.7
2.2
u/l
58.7
56.2
0.28
90
701
(3007164) IgA [Mass/volume] in Serum or Plasma
65
454
1.55
2.39
2.0
1.3
g/l
2.3
2.5
0.60
40
263
(40765096) Chromosome analysis panel by Banding
5
8
6.33
2.38
1.4
1.0
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
51
338
1.61
2.34
31.2
20.9
inr
1.4
1.3
—
8
46
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
29
164
1.85
2.32
3.7
2.6
mmol/l
1.2
1.2
0.80
29
143
(40768443) Skin Pathology biopsy report
19
92
2.13
2.32
1.3
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
46
298
1.64
2.31
1.6
1.4
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
8
23
3.54
2.28
1.5
1.6
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
264
2422
1.59
2.27
22.1
12.1
mg/l
22.1
21.4
0.12
232
1839
(3011397) Hemoglobin [Presence] in Urine by Test strip
74
538
1.49
2.25
4.9
3.7
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
98
753
1.44
2.25
2.9
3.0
ng/l
1230.5
1268.8
0.04
88
640
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
5
9
5.62
2.22
1.6
1.0
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
8
24
3.39
2.19
1.0
1.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
22
116
1.96
2.17
10.9
7.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
7
19
3.74
2.16
1.7
2.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
32
192
1.74
2.13
3.1
2.1
ml/min/173m2
79.4
64.7
—
10
78
(3019230) Fractional oxyhemoglobin in Venous blood
10
37
2.76
2.12
4.3
1.8
%
62.9
61.7
—
10
37
(3008757) Leukocyte morphology finding [Identifier] in Blood
7
20
3.56
2.06
4.1
3.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
60
425
1.51
2.06
1.3
1.3
iu/ml
38.7
31.7
0.17
21
142
(3021788) Differential panel - Synovial fluid
11
44
2.55
2.03
1.7
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
99
775
1.41
2.03
3.9
3.2
mg/l
81.7
142.2
0.30
63
487
(3003396) Base excess in Arterial blood by calculation
39
251
1.63
2.02
9.2
6.2
mmol/l
1.3
1.6
0.20
30
197
(3044927) Protein electrophoresis panel - Urine
9
32
2.86
2.01
1.6
1.1
—
—
—
0
0
(44790048)
7
21
3.38
1.97
1.3
1.6
—
—
—
0
0
(44806118)
7
21
3.38
1.97
1.3
1.6
—
—
—
0
0
(44790049)
7
21
3.38
1.97
1.3
1.6
—
—
—
0
0
(44790047)
7
21
3.38
1.97
1.3
1.6
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
64
464
1.48
1.97
3.2
2.2
e6/l
3.7
5.2
1.19
52
405
(3028433) Virus identified in Specimen by Culture
5
11
4.60
1.95
1.0
1.2
—
—
—
0
0
(3000492) Spirometry study
35
222
1.65
1.92
1.5
1.4
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
49
338
1.53
1.91
1.4
1.3
titre
510.0
530.9
—
8
88
(3024354) Oxygen [Partial pressure] in Venous blood
32
199
1.68
1.89
2.5
2.6
kpa
4.6
4.4
0.18
32
191
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
6
17
3.58
1.84
1.2
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
15
73
2.11
1.84
1.3
1.1
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
7
23
3.09
1.81
1.4
2.0
pg
32.7
33.8
—
7
23
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
8
29
2.80
1.80
1.5
1.5
—
—
—
0
0
(3044889) 12 lead EKG panel
195
1723
1.35
1.79
4.6
3.8
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
20
110
1.87
1.77
4.6
3.4
mmol/l
25.2
25.0
0.16
20
102
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
10
41
2.49
1.77
1.4
1.4
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
31
195
1.65
1.77
7.3
5.6
mmol/l
1.8
1.3
0.87
31
187
(3020682) Albumin/Creatinine [Ratio] in Urine
103
829
1.36
1.75
4.9
3.9
mg/mmol
15.2
8.9
0.36
68
528
(3011648) Oxygen content in Venous blood
6
18
3.38
1.75
1.2
1.5
%
13.2
11.6
—
6
18
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
47
328
1.51
1.74
5.0
4.9
%
30.4
31.8
0.45
31
212
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
17
89
1.96
1.73
2.1
2.1
ug/l
153.4
835.5
0.72
17
80
(42529406) Shigella sp [Presence] in Stool by Culture
15
75
2.05
1.72
1.3
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
14
3.61
1.62
1.2
1.3
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
14
3.61
1.62
1.6
4.1
—
—
—
0
0
(3017704) Immunofixation for Urine
5
14
3.61
1.62
1.2
1.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
23
137
1.73
1.60
1.7
1.5
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
7
26
2.73
1.59
1.6
1.3
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
26
2.73
1.59
1.7
1.3
—
—
—
0
0
(40768793) Breast Pathology biopsy report
6
20
3.04
1.59
1.7
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
11
50
2.24
1.59
2.1
1.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
67
513
1.39
1.54
5.6
4.3
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
5
15
3.37
1.53
2.0
1.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
5
15
3.37
1.53
2.0
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
5
15
3.37
1.53
1.4
1.3
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
5
15
3.37
1.53
2.0
1.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
24
147
1.69
1.52
5.7
4.5
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
11
51
2.20
1.52
2.3
2.3
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
28
179
1.62
1.52
2.4
3.8
ng/l
74.2
84.4
0.46
23
158
(40761511) CBC panel - Blood by Automated count
273
2574
1.48
1.51
18.9
11.6
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
6
21
2.89
1.51
1.2
1.0
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
10
45
2.26
1.48
1.4
1.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
46
332
1.45
1.46
1.2
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
14
73
1.96
1.46
1.4
1.1
—
—
—
0
0
(4146454)
7
28
2.53
1.46
4.3
3.0
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
16
3.16
1.44
1.8
1.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
6
22
2.76
1.44
1.7
1.4
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
115
965
1.30
1.43
4.3
3.6
ng/l
27.3
76.7
0.78
86
684
(3039443) Prostate specific Ag panel - Serum or Plasma
11
53
2.11
1.40
2.1
1.6
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
9
41
2.23
1.38
1.0
1.1
—
22.0
—
0
6
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
6
23
2.64
1.37
2.5
3.7
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
21
128
1.69
1.37
2.0
2.3
%
1.5
1.3
0.30
21
128
(3022145) Colonoscopy Study observation
33
226
1.51
1.36
1.3
1.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
100
829
1.30
1.35
3.9
3.1
mmol/l
7.4
7.7
0.27
84
702
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
261
2453
1.39
1.35
5.3
4.6
mmol/l
6.1
6.0
0.89
236
2230
(40761535) Cells panel - Urine sediment
30
202
1.54
1.33
5.6
3.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
9
43
2.12
1.31
2.7
1.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
5
18
2.81
1.29
2.2
2.7
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
169
1505
1.27
1.28
3.6
2.9
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
245
2287
1.33
1.27
6.1
4.6
mu/l
1.9
2.5
0.58
228
2097
(3000330) Specific gravity of Urine by Test strip
21
132
1.63
1.24
3.9
3.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
11
56
2.00
1.23
1.0
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
10
49
2.08
1.23
1.2
1.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
8
37
2.19
1.22
1.9
1.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
54
415
1.36
1.22
1.4
1.3
u/ml
37.6
10.9
0.64
12
168
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
5
19
2.66
1.22
3.6
1.8
—
—
—
0
0
(3022313) Gas panel - Capillary blood
20
125
1.64
1.21
4.8
3.0
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
26
2.33
1.19
1.2
1.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
6
26
2.33
1.19
1.2
1.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
75
609
1.30
1.17
1.3
1.4
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
34
0.00
1.16
0.0
1.5
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
25
167
1.54
1.16
5.2
3.0
kpa
5.2
5.2
0.01
25
154
(3021960) Folate [Moles/volume] in Serum or Plasma
72
584
1.30
1.14
1.6
1.5
nmol/l
20.2
21.4
0.31
59
498
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
15
88
1.74
1.13
1.5
1.3
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
22
144
1.57
1.12
1.4
1.3
—
62.7
—
0
9
(3020564) Creatinine [Moles/volume] in Serum or Plasma
275
2626
1.40
1.11
24.7
13.9
umol/l
78.9
77.9
0.26
275
2626
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
65
522
1.31
1.10
1.7
1.7
pmol/l
128571919.0
11468324.5
0.43
49
436
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
23
153
1.54
1.10
1.3
1.5
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
7
32
2.21
1.08
1.0
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
7
33
2.15
1.06
1.6
2.0
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
7
34
2.08
1.03
5.1
3.1
nmol/l
0.8
1.0
—
7
27
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
81
676
1.27
1.03
1.7
1.7
mmol/l
1.5
1.4
0.27
60
568
(3004716) Salmonella sp identified in Stool by Organism specific culture
18
115
1.60
1.02
1.3
1.3
—
—
—
0
0
(3015736) pH of Urine
106
914
1.24
1.01
4.5
3.5
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
245
2311
1.28
1.01
20.4
10.8
ml/min/173m2
79.6
80.1
0.15
216
1867
(3020891) Body temperature
15
92
1.66
0.99
3.8
4.5
—
—
—
0
0
(21494434) Karyotype in Bone marrow
5
23
2.19
0.98
1.0
1.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
5
23
2.19
0.98
2.2
1.3
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
0
31
0.00
0.97
0.0
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
13
77
1.72
0.96
1.6
1.6
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
59
477
1.29
0.96
3.2
2.6
ug/l
0.8
0.8
0.02
39
300
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
32
0.00
0.95
0.0
1.5
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
248
2348
1.27
0.95
7.4
6.0
mmol/mol
41.0
40.0
0.84
230
2187
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
13
78
1.70
0.93
2.5
2.3
ug/min
82.9
57.4
—
8
46
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
6
29
2.09
0.90
1.2
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
6
30
2.02
0.87
1.2
1.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
130
1161
1.21
0.86
6.5
5.0
estimate
0.0
0.0
0.00
17
200
(3048689) Calprotectin [Mass/mass] in Stool
36
276
1.34
0.85
2.5
2.1
ug/g
138.3
133.6
0.03
29
219
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
40
312
1.32
0.85
11.6
6.5
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
132
1183
1.20
0.84
5.2
3.6
estimate
0.0
0.0
0.00
14
195
(3045424) Erythrocytes [Presence] in Urine
6
32
1.89
0.82
3.0
1.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
16
232
0.67
0.78
1.6
1.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
251
2398
1.24
0.77
4.5
4.1
mmol/l
1.3
1.3
0.42
221
2200
(3022806) Fractional oxyhemoglobin in Capillary blood
6
34
1.78
0.76
1.3
1.7
%
84.4
90.6
—
6
34
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
265
2549
1.26
0.75
5.6
5.1
mmol/l
2.6
2.7
1.12
238
2356
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
274
2646
1.29
0.74
14.7
8.8
u/l
24.6
26.1
1.08
262
2540
(3023103) Potassium [Moles/volume] in Serum or Plasma
266
2561
1.26
0.73
25.6
14.3
mmol/l
4.0
4.0
0.30
260
2488
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
10
60
1.69
0.73
2.6
1.3
—
1.1
—
0
7
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
12
76
1.60
0.72
1.3
1.7
nmol/l
43.2
40.0
0.13
12
71
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
12
76
1.60
0.72
2.0
1.6
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
15
101
1.51
0.71
1.1
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
62
524
1.23
0.71
1.4
1.3
u/ml
0.9
1.8
1.17
11
134
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
5
26
1.94
0.71
1.4
1.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
128
1159
1.18
0.70
5.0
3.6
estimate
0.0
0.0
0.00
17
202
(3022621) pH of Urine by Test strip
22
161
1.39
0.70
4.3
2.8
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
89
782
1.19
0.69
2.2
2.2
u/l
147.7
267.4
0.67
84
728
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
11
69
1.62
0.69
1.1
1.1
—
20.9
—
0
9
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
29
224
1.32
0.67
4.2
3.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
24
181
1.35
0.65
2.5
2.9
e9/l
3.7
3.7
0.07
19
142
(3038177) Helicobacter pylori Ab [Presence] in Serum
5
30
1.68
0.61
1.0
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
6
36
1.68
0.57
1.2
1.1
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
283
2760
1.27
0.57
30.9
17.8
e9/l
6.8
6.7
0.49
277
2682
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
6
38
1.59
0.54
2.0
2.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
6
38
1.59
0.54
1.7
1.3
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
6
38
1.59
0.54
4.7
3.1
e9/l
3.1
4.5
—
6
38
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
6
39
1.55
0.53
1.5
1.3
pmol/l
67.7
60.3
—
6
39
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
6
39
1.55
0.53
6.5
3.6
%
57.3
58.3
—
6
39
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
10
67
1.51
0.50
1.1
1.1
—
3.6
—
0
9
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
12
84
1.45
0.50
1.2
1.9
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
33
272
1.24
0.50
1.8
1.6
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
21
163
1.31
0.49
1.1
1.2
iu/ml
31.7
110.3
—
7
70
(1761482) Bacteria [#/volume] in Urine by Culture
11
76
1.46
0.48
4.4
3.8
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
16
121
1.34
0.45
2.5
2.3
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
10
69
1.46
0.45
1.1
1.1
—
11.0
—
0
10
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
5
31
1.62
0.43
1.2
1.2
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
29
241
1.22
0.42
2.4
2.5
ug/l
6.9
6.6
0.05
29
209
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
255
2480
1.15
0.41
5.1
4.6
mmol/l
1.4
1.5
0.79
229
2289
(3028626) Oxygen [Partial pressure] in Capillary blood
8
60
1.34
0.40
4.8
2.1
kpa
7.8
8.3
—
8
54
(3016650) Hepatitis A virus Ab [Presence] in Serum
5
34
1.48
0.40
1.0
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
5
35
1.44
0.39
1.4
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
5
35
1.44
0.39
1.4
1.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
94
867
1.12
0.38
5.3
3.7
ug/l
3.9
1.9
0.85
81
772
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
19
234
0.80
0.37
2.4
2.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
5
37
1.36
0.37
1.6
1.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
75
684
1.13
0.37
4.2
3.6
%
23.3
24.2
0.25
40
303
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
6
41
1.47
0.36
1.5
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
6
41
1.47
0.36
1.5
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
6
41
1.47
0.36
1.5
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
6
41
1.47
0.36
1.5
1.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
14
108
1.31
0.36
2.4
1.6
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
256
2498
1.14
0.35
5.1
4.6
mmol/l
4.5
4.6
0.81
230
2316
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
6
43
1.40
0.35
1.7
1.7
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
6
43
1.40
0.35
2.5
2.3
mmol/l
4.4
4.1
—
6
43
(3035285) Chloride [Moles/volume] in Venous blood
6
43
1.40
0.35
2.5
2.3
mmol/l
104.3
105.3
—
6
43
(3033705) Calcium.ionized [Moles/volume] in Venous blood
6
43
1.40
0.35
2.5
2.3
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
10
74
1.36
0.32
1.9
1.7
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
7
52
1.35
0.31
1.3
1.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
15
120
1.26
0.30
1.4
1.2
—
—
—
0
0
(4010399)
23
195
1.19
0.29
1.3
1.4
—
—
—
0
0
(3010421) pH of Blood
8
65
1.24
0.27
8.5
3.3
ph
7.4
7.4
—
8
54
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
10
77
1.31
0.26
1.5
1.3
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
60
552
1.11
0.26
5.7
3.9
kg/l
1.0
1.0
—
10
82
(36660697) Celiac disease serology panel - Serum
22
188
1.18
0.26
1.4
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
34
302
1.14
0.26
1.2
1.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
19
161
1.19
0.24
1.7
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
60
648
0.91
0.24
3.8
3.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
6
81
0.74
0.24
1.2
1.8
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
6
82
0.73
0.24
1.2
2.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
6
82
0.73
0.24
1.2
2.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
6
82
0.73
0.24
1.2
2.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
18
210
0.85
0.23
2.2
1.9
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
5
40
1.25
0.22
6.2
1.9
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3004451) EKG impression Narrative
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
10
0.00
0.21
0.0
1.1
—
6.4
—
0
10
(3015183) Erythrocyte sedimentation rate
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
6
48
1.25
0.20
1.8
1.5
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
14
0.00
0.20
0.0
2.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
6
49
1.23
0.20
1.3
1.7
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
6
53
1.13
0.19
1.3
3.8
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
7
58
1.21
0.18
1.0
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
11
91
1.22
0.18
1.3
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
6
78
0.76
0.15
1.0
2.3
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
5
47
1.06
0.09
1.0
2.9
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
6
54
1.11
0.09
1.0
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
5
63
0.79
0.08
1.0
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
23
217
1.06
0.06
1.5
1.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
91
928
0.97
0.05
5.3
3.7
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
10
90
1.11
0.05
2.8
1.9
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
11
119
0.92
0.04
1.1
1.0
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
23
220
1.05
0.03
2.0
1.8
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
16
151
1.06
0.03
1.5
1.5
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
61
620
0.98
0.02
6.0
3.9
estimate
0.0
0.0
0.00
17
198
(1761868) Lipid panel - Serum or Plasma
92
912
1.01
0.01
3.5
3.0
—
—
—
0
0
(4034850)
10
94
1.07
0.01
17.0
7.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
19
184
1.03
0.00
2.1
1.7
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
18
185
0.97
0.00
5.1
3.2
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
7
0.00
0.00
0.0
2.7
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
3.6
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
5.9
—
0
5
(3000285) Sodium [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.3
—
1.6
—
0
6
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
7
0.00
0.00
0.0
2.7
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
6
0.00
0.00
0.0
2.3
—
1.3
—
0
6
(3051101) Glucose [Moles/volume] in Cord blood
0
6
0.00
0.00
0.0
5.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
6
65
0.92
0.00
1.0
2.5
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
7
72
0.97
0.00
1.6
1.5
—
—
—
0
0
(4094501)
7
69
1.01
0.00
1.1
1.1
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(1002224) Polysomnography panel
12
120
1.00
0.00
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
7
73
0.96
0.00
3.1
1.9
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_NASOPHARYNX_EXALLC – Benign neoplasm: Nasopharynx
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).